A Dolutegravir-Associated Hyperglycemia Computational Prediction Tool for People Living with HIV in Uganda-Reference-Cited by-同舟云学术

A Dolutegravir-Associated Hyperglycemia Computational Prediction Tool for People Living with HIV in Uganda

Published:2024 Issue: Volume: Page:165-181
ISSN:2196-8705
Container-title:Progress in IS
language:en
Short-container-title:

Author:

Favor Ceaser Wisdom,Ramadhan Sinde,Kisangiri Michael,Mugenyi Levicatus,Musinguzi Francis,Balaba Martin,Owarwo Noela,Laker Eva,Obaikol Ruth,Kiraga Agnes,Castelnuovo Barbara,Parkes-Ratanshi Rosalind

Publisher

Springer Nature Switzerland

Link

https://link.springer.com/content/pdf/10.1007/978-3-031-56576-2_15

Reference35 articles.

1. WHO. (2021). World Health Organisation (WHO). [Online]. Retrieved October 4, 2021, from https://apps.who.int/iris/bitstream/handle/10665/277395/WHO-CDS-HIV-18.51-eng.pdf?sequence=1&isAllowed=y

2. Dow, D. E., & Bartlett, J. A. (2014). Dolutegravir, the second-generation of integrase Strand transfer inhibitors (INSTIs) for the treatment of HIV. Infectious Diseases and Therapy Springer Link, 3(2), 83–102.

3. Scali, I., & Abernathy, A. (2021). [Online]. Retrieved October 4, 2021, from https://viivhealthcare.com/en-gb/media/press-releases

4. van Lunzen, J., Maggiolo, F., Arribas, J. R., Rakhmanova, A., Yeni, P., Young, B., Rockstroh, J. K., Almond, S., Song, I., Brothers, C., & Min, S. (2012). Once daily dolutegravir (S/GSK1349572) in combination therapy in antiretroviral-naive adults with HIV: Planned interim 48 week results from SPRING-1, a dose-ranging, randomised, phase 2b trial. Lancet, 12(2), 111–118.

5. Cahn, P., Pozniak, A., Horacio, M., Andrey, S., Brites, C., Andrade-Villanueva, J. F., Richmond, G., Buendia, C. B., Fourie, J., Ramgopal, M., Hagins, D., Felizarta, F., Madruga, J., & Reuter. (2013). Dolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV: Week 48 results from the randomised, double-blind, non-inferiority SAILING study. Lancet, 382(9893), 700–708.